Heart transplantation in patients over 55;Il trapianto cardiaco dopo i 55 anni

Giornale Italiano di Cardiologia

Volumn 27, Issue 3, 1997, Pages 263-269

  Pederzolli, Carlo ^a,b   Martinelli, Luigi ^a   Grande, Antonino M ^a   Goggi, Claudio ^a   Minzioni, Gaetano ^a   Castiglione, Nicoletta ^a   Gavazzi, Antonello ^b   Campana, Carlo ^b   Viganò, Mario ^a  

^a Centro C Dubost   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Elderly patients; Heart transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGED; AGING; ARTICLE; CLINICAL TRIAL; DONOR; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATIENT SELECTION; PHYSIOLOGY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURVIVAL;

AGED; AGING; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 0031088002     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. OLIVARI MT, ANTOLICK A, KAYE MP, JAMIESON SW, RING WS: Heart transplantation in elderly patients. J Heart Transplant 1988; 7: 258-264.
2. COSTARD-JACKLE A, HILL I, SCHROEDER JS, FOWLER MB: The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991, 84 (Suppl III): 329-337.
3. FUSTER V, GERSH BJ, GIULIANI ER: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1991; 47: 525-531.
4. BOURGE RC, NAFTEL DC, COSTANZO-NORDIN MR ET AL, AND THE TRANSPLANT CARDIOLOGISTS RESEARCH DATABASE GROUP: Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993; 12: 549-562.
5. HARLAN WR, OBERMAN A, GRIMM R: Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern Med 1987; 86: 133-138.
6. KIRKLIN JK, NAFTEL DC, MCGIFFIN DC, MCVAY RF, BLACKSTONE EH, KARP RB: Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988; 5: 917-924.
7. KAYE MP: The Registry of the International Society of Heart and Lung Transplantation: 9th official report - 1992. J Heart Lung Transplant 1992; 11: 599-606.
8. MARTINELLI L, RINALDI M, PEDERZOLLI C, ET AL: Different results of cardiac transplantation in patients with ischemic and dilated cardiomyopathy. Eur J Cardio-Thorac Surg 1995; 9: 644-650.
9. ALDERMAN EL, FISHER LD, LITWIN P: Results of coronary artery surgery in patients with poor left ventricular function. Circulation 1983; 68: 785-795.
10. KRON IL, FLANAGAN TL, BLACKBOURNE LH, SHROEDER RA, NOLAN SP: Coronary revascularization rather then cardiac transplantation for ischemic cardiomyopathy. Ann Surg 1989; 210: 348-354.
11. JAMIESON SW, OYER PE, BALDWIN J, BILLINGHAM ME, STINSON EB, SHUMWAY NE: Heart transplantation for end-stage ischemic heart disease; the Stanford experience. Heart Transplant 1984; 3: 224-226.
12. DIES F: Intermittent dobutamine in ambulatory patients with chronic cardiac failure. Br J Clin Prac 1986; 40 (Suppl 45): 37-39.
13. MILLER LW: Outpatient dobutamine for refractory congestive heart failure: advantages, techniques and results. J Heart Lung Transplant 1991; 10: 482-487.
14. GAGE J, RUTMAN H, LUCIDO D: Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performances in patients with severe heart failure. Circulation 1986; 74: 367-373.
15. THE CONSENSUS TRIAL STUDY GROUP: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-1435.
16. ROYSTON D, TAYLOR KM, BIDSTRUP BP, SAPSFORD RN: Effect of aprotinine on need for blood transfusion after repeat open heart surgery. Lancet 1987; 2: 1289-1291.
17. SCHULER S, PARNT R, WARNECKE H, HETZER R: Extended donor criteria for heart transplantation. J Heart Transplant 1988; 7: 326-330.
18. MYERS BD, ROSS J, NEWTON L, LEUTSCHER J, PERLROTH M: Cyclosporine associated chronic nephropathy. N Engl J Med 1984; 311: 699-705.
19. SARRIS GE, MOORE KA, SHROEDER JS, ET AL: Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994; 108: 240-252.
20. OLIVARI MT, ANTOLICK A, RING WS: Arterial hypertension in heart transplant recipients treated with triple drug immunosuppression therapy. J Heart Transplant 1989; 7: 254-257.
21. GAO S, SCHROEDER JS, ALDERMAN E: Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patients. Circulation 1987; 76 (Suppl V): 56-61.
22. O'NEILL BJ, PFLUGFELDER PW, SINGH NR, MENKIS AH, MCKENZIE FN, KOSTUK MJ: Frequency of angiographic detection and quantitative assessment of coronary arterial disease 1 and 3 years after cardiac transplantation. Am J Cardiol 1989; 63: 1221-1226.
23. SCHROEDER JS, GAO S, HUNT SA, STINSON EB: Accelerated graft coronary artery disease: diagnosis and prevention. J Heart Lung Transplant 1992; 11: S258-S266.
24. EICH D, THOMPSON JA, KO D: Hypercholesterolemia in long term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10: 45-49.
25. LADOWSKY JS, KORMOS RL, LEE A: Post-transplant diabetes in heart transplant recipients (abstract). J Heart Transplant 1988; 7: 115.
26. MUNOZ E, LONQUIST JL, RADOVANCEVIC B, ET AL: Long term results in diabetic patients undergoing heart transplantation. J Heart Lung Transplant 1992; 11: 943-949.
27. NARROD J, KORMOS R, ARMITAGE J, HARDESTY R, LADOWSKI J, GRIFFITH B: Acute rejection and coronary artery disease in long term survivors of heart transplantation. J Heart Transplant 1989; 8: 418-421.
28. PENN I: Cancers after cyclosporine therapy. Transpl Proc 1988; 20 (Suppl I): 276-279.
29. STEED DL, BROWN B, REILLY JJ, ET AL: General surgical complication in heart and heart-lung transplantation. Surgery 1985; 98: 739-745.